Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN114306624B. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114306624B discloses a biotin-conjugated photosensitizer enabling Type I/II PDT. Offers reliable supply for hypoxic tumor treatment intermediates.